Supplementary Figure 1 | Genetic ablation of adult-born granule neurons (a) Time line showing the experimental design. (b) Representative microscopic images from three independent experiments showing dentate gyrus doublecortin (DCX) immunostaining in mice treated with either vehicle (Veh) or ganciclovir (GCV) for 4 weeks. Scale bar is 100 μm. Inset shows the cells expressing DCX. Scale bar is 20 μm. (c) A graph showing the number of DCX-expressing newborn neurons in the dentate gyrus in Veh (n=4) and GCV group (n = 5). Mann-Whitney U test, P = 0.016, U < 0.001. Data present as mean ± s.e.m. *P < 0.05. Nestin-TK, Nestin-δ-HSVthymidine kinase-EGFP transgenic mice. Supplementary Figure 2 | Ablating neurogenesis before seizures does not affect MFS (a) Time line to show experimental design. (b) Representative microscopic images from three independent experiments showing hippocampal zinc transporter-3 (ZnT3) immunoreactivity, a marker for the axons of granule cells, in epilepsy. Scale bar is 100 μm. Higher magnification images of ZnT3 immunoreactivity are shown in the right panel. Scale bar is 20 μm. (c) A graph measuring ZnT3-positive areas in IML of the dentate gyrus between Veh/Pilo (n = 8) and GCV/pilo groups (n = 7). Mann-Whitney U test, P = 0.298, U = 19.000. Data present as mean ± s.e.m. ns, not significant. GCV, ganciclovir; Veh, vehicle; Nestin-TK, Nestin-δ-HSV-thymidine kinase-EGFP transgenic mice; Pilo, pilocarpine; IML, inner molecular layer; GCL, granule cell layer; MFS, mossy fiber sprouting. Supplementary Figure 3 | NeuroD is required for seizure-induced neurogenesis (a) Time line to show experimental design. (b) Representative fluorescent images from four independent experiments showing NeuroD induction in the dentate gyrus by kainic acid (KA). Scale bar is 50 μm. Insets show NeuroD-expressing cells in the dentate gyrus at a higher magnification. Scale bar is 20 μm. (c) Graphs showing NeuroD-expressing cells in the granule cell layer (GCL) and the hilus between sham and KA groups (n = 6 per group). Mann-Whitney U test, P = 0.004, U = 0.000 for the left graph; Mann-Whitney U test, P = 0.045, U = 5.500 for the right graph. (d) Experimental time line. Tamoxifen (TAM) was injected for 5 days to label newborn cells, followed by KA injection one week later. (e) Representative confocal images from three independent experiments showing a YFP-, Ki67-, and DCX-positive cell; a proliferating neuroblasts (arrow). Scale bar is 20 μm. (f) A graph showing the number of YFP/DCX/Ki67-expressing cells between NeuroD wild-type (WT) (n = 7) and conditional knockout (cKO) group (n = 8). Student's t-test, P = 0.032, t(13) = 2.397. (g) Representative confocal images from five independent experiments showing YFP/Prox1-immunoreactive cells in the dentate gyrus. Scale bar is 50 μm. Insets show YFP/Prox1-labeled cells in GCL and the hilus. Scale bar is 20 μm. (h) Graphs showing the number of YFP/Prox1-expressing cells in GCL and the hilus between NeuroD WT (n = 9) and cKO group (n = 10). Student's t-test, P = 0.002, t(17) = 3.610 for the left graph; Mann-Whitney U test, P = 0.018, U = 16.500 for the right graph. Data present as mean ± s.e.m. *P < 0.05. YFP, yellow fluorescent protein; DCX, doublecortin; Prox1, prospero homeobox 1; EGCs, ectopic granule cells.

